medroxyprogesterone acetate has been researched along with Depressive Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berry-Bibee, EN; Curtis, KM; Nanda, K; Pagano, HP; Zapata, LB | 1 |
| Inan, I; Kelekci, S; Yilmaz, B | 1 |
1 review(s) available for medroxyprogesterone acetate and Depressive Disorder
| Article | Year |
|---|---|
Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review.
Topics: Bipolar Disorder; Contraceptives, Oral; Depressive Disorder; Equipment Safety; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate; Pregnancy; Pregnancy, Unplanned; Psychiatric Status Rating Scales; Risk Assessment | 2016 |
1 trial(s) available for medroxyprogesterone acetate and Depressive Disorder
| Article | Year |
|---|---|
Psychological effects of tibolone and sequential estrogen-progestogen therapy in perimenopausal women.
Topics: Depressive Disorder; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Perimenopause; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome | 2005 |